Welcome to our dedicated page for Indivior news (Ticker: INDV), a resource for investors and traders seeking the latest updates and insights on Indivior stock.
Indivior PLC (INDV) is a global leader in developing treatments for substance use disorders, with a focused pipeline addressing opioid addiction and related mental health challenges. This page aggregates all material news and official communications from the pharmaceutical innovator, providing stakeholders with a centralized resource for informed decision-making.
Key updates include regulatory filings, clinical trial results, product launch announcements, and strategic partnerships. Investors gain direct access to earnings reports, R&D milestones, and market expansion initiatives while maintaining compliance with disclosure requirements across jurisdictions.
Content categories encompass FDA/EMA regulatory decisions, patent developments, manufacturing updates, and peer-reviewed research publications. Each news item is presented in its original context with clear sourcing to preserve informational integrity.
Bookmark this page for real-time tracking of Indivior's progress in combating addiction through medical innovation. Cross-reference historical announcements with current performance metrics using our chronological news archive.
Indivior, a leading addiction treatment company, will host an analyst teach-in event in New York City, confirming its FY 2024 guidance. The company expects net revenue between $1,240m and $1,330m, an 18% increase from FY 2023. SUBLOCADE revenue is projected at $820m to $880m, a 35% rise. OPVEE revenue is anticipated to be $15m to $25m, and PERSERIS revenue is forecasted at $55m to $65m, a 43% increase. SUBOXONE Film market share is expected to decline by 1-2 percentage points. Adjusted gross margin is estimated to be in the low to mid-80s range.
Adjusted SG&A expenses are projected at $575m to $590m, with R&D expenses between $120m and $130m. Adjusted operating profit is expected to be $330m to $380m. The event will be webcast and aims to provide an in-depth overview of Indivior's growth and value creation strategies.
FAQ
What is the current stock price of Indivior (INDV)?
What is the market cap of Indivior (INDV)?
